Medical and surgical management of chronic ulcerative colitis

Archives of Surgery

Volumn 140, Issue 3, 2005, Pages 300-310

  Cima, Robert R ^b   Pemberton, John H ^a  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID DERIVATIVE; ANTIBIOTIC AGENT; ANTIMETABOLITE; ASOCOL; AZATHIOPRINE; BUDESONIDE; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOSPORIN; CYTOKINE; ENEMA; GLUCOCORTICOID; HYDROCORTISONE; IMMUNOSUPPRESSIVE AGENT; INDUCIBLE NITRIC OXIDE SYNTHASE; INFLIXIMAB; INTERLEUKIN 1; INTERLEUKIN 8; MERCAPTOPURINE; MESALAZINE; PREDNISONE; PRODRUG; PURINE NUCLEOTIDE; ROSAWA; SALAZOSULFAPYRIDINE; SULFAMETHOXAZOLE; SULFAPYRIDINE; THIOPURINE METHYLTRANSFERASE; TIOGUANINE; TRIMETHOPRIM; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; UNINDEXED DRUG; MONOCLONAL ANTIBODY;

AGE DISTRIBUTION; ANAPHYLAXIS; ANASTOMOSIS; ANEMIA; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC THERAPY; ANTIINFLAMMATORY ACTIVITY; BLEEDING; BLOOD TOXICITY; BLOOD TRANSFUSION; BONE MARROW SUPPRESSION; CANCER RISK; CLINICAL TRIAL; COLITIS; COLON DISEASE; COLON RESECTION; COLONOSCOPY; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DRUG ABSORPTION; DRUG CLEARANCE; DRUG EXCRETION; DRUG FATALITY; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG MEGADOSE; DRUG METABOLISM; DRUG RECEPTOR BINDING; FERTILITY; FISTULA; FLUID THERAPY; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HYPERTENSION; ILEITIS; ILEOSTOMY; ILEUM POUCH ANUS ANASTOMOSIS; IMMUNE DEFICIENCY; IMMUNOLOGICAL TOLERANCE; INTESTINE SURGERY; KIDNEY FAILURE; LAPAROSCOPIC SURGERY; LEUKOPENIA; LIVER TOXICITY; LONG TERM CARE; LOW DRUG DOSE; LYMPHOMA; NASOGASTRIC TUBE; NAUSEA; NEPHROTOXICITY; NEUTROPENIA; NONHUMAN; OPPORTUNISTIC INFECTION; PANCREATITIS; PNEUMOCYSTIS PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; REPRODUCTIVE TOXICITY; REVIEW; SEIZURE; SKIN MANIFESTATION; SMALL INTESTINE OBSTRUCTION; SPERMATOGENESIS; SUPERINFECTION; SURGICAL STAPLING; SURGICAL TECHNIQUE; THROMBOCYTOPENIA; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME; ULCERATIVE COLITIS; VOMITING; CHRONIC DISEASE; COLON POUCH; ELECTIVE SURGERY; EMERGENCY; FEMALE; LAPAROSCOPY; MALE; SUTURING METHOD;

ANASTOMOSIS, SURGICAL; ANTIBODIES, MONOCLONAL; CHRONIC DISEASE; COLECTOMY; COLITIS, ULCERATIVE; COLONIC POUCHES; EMERGENCIES; FEMALE; GLUCOCORTICOIDS; HUMANS; ILEOSTOMY; IMMUNOSUPPRESSIVE AGENTS; LAPAROSCOPY; MALE; MESALAMINE; POSTOPERATIVE COMPLICATIONS; SURGICAL PROCEDURES, ELECTIVE; SURGICAL STAPLING; SUTURE TECHNIQUES;

EID: 16244377146     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.140.3.300     Document Type: Review

References (75)

1. Loftus EV, Silverstein MD, Sandborn WJ, et al. Ulcerative colitis in Olmstead County, Minnesota, 1940-1993: incidence, prevalence and survival. Gut. 2000;46:336-343.
2. American Gastroenterological Association. Chronic intestinal disorders. In: The Burden of Gastrointestinal Disease. Bethesda, Md: American Gastroenterological Association; 2001:27-40.
3. Truelove SC, Witts LJ. Cortisone in ulcerative colitis: preliminary report on therapeutic trial. BMJ. 1954;2:375-378.
4. Truelove SC, Witts LJ. Cortisone in ulcerative colitis: final report on a therapeutic trial. BMJ. 1955;2:1041-1048.
5. Misiewicz JJ, Lennard-Jones JE, Connell AM, et al. Controlled trial of sulfasalazine in maintenance therapy for ulcerative colitis. Lancet. 1965;285:185-188.
6. Azad Khan AK, Piris J, Truelove SC. An experiment to determine the active therapeutic moiety of sulphasalazine. Lancet. 1977;2:892-895.
7. Felder JB, Korelitz BI, Rajapakse R, et al. Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study. Am J Gastroenterol. 2000;95:1949-1954.
8. Papadakis KA, Targan SR. Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu Rev Med. 2000;51:289-298.
9. Ahnfelt-Ronne I, Nielson OH, Christensen A, et al. Clinical evidence supporting the radical scavenger mechanism of 5-aminosalicylic acid. Gastroenterology. 1990;98:1162-1169.
10. Katz S. Update in medical therapy of ulcerative colitis: a practical approach. J Clin Gastroenterol. 2002;34:397-407.
11. Rao SS, Cann PA, Holdsworth CD. Clinical experience of tolerance of mesalazine and olsalazine in patients intolerant to sulfasalazine. Scand J Gastroenterol. 1987;22:332-336.
12. Gronemeyer H. Control of transcription activation by steroid hormone receptors. FASEB J. 1992;6:2524-2529.
13. Cann PA, Holdworth CD. Systemic absorption from hydrocortisone foam enema in ulcerative colitis. Lancet. 1987;1:922-923.
14. Petitjean O, Wendling JL, Tod M, et al. Pharmacokinetics and absolute rectal bioavailability of hydrocortisone acetate in distal colitis. Aliment Pharmacol Ther. 1992;6:351-357.
15. Lennard L. The clinical pharmacology of 6-mercaptopurine. Eur J Clin Pharmacol. 1992;43:329-339.
16. + T lymphocytes: a mechanism for azathioprine mediation in IBD based on induction of T cell apoptosis [abstract]. Gastroenterology. 2002;122:A14.
17. Lennard L, Van Loon JA, Weinshilboum RM. Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphism. Clin Pharmacol Ther. 1989;46:149-154.
18. Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 2004;99:1371-1385.
19. Present DH, Meltzer SJ, Krumholz MP, et al. 6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity. Ann Intern Med. 1989;111:641-649.
20. Connell WR, Kamm MA, Dickson M, et al. Long term neoplasia risk after azathioprine treatment in inflammatory bowel disease. Lancet. 1994;343:1249-1252.
21. Lichtiger S, Present DH, Kornbluth A, et al. Cyclosporin in severe ulcerative colitis refractory to steroid therapy. N Engl J Med. 1994;330:1841-1845.
22. Hess AD. Mechanisms of action of cyclosporin: considerations for the treatment of autoimmune diseases. Clin Immunol Immunopathol. 1993;68:220-228.
23. Sternthal MGJ, Kornbluth A. Toxicity associated with the use of cyclosporin in patients with inflammatory bowel disease [abstract]. Gastroenterology. 1996;110:A1019.
24. Loftus CG, Loftus EV, Sandborn WJ. Cyclosporin for refractory ulcerative colitis. Gut. 2003;52:172-173.
25. Sands BE. Biological: principles, techniques and mechanisms of action. Acta Gastroenterol Belg. 2001;64:165-169.
26. Sands BE. Biological therapies for ulcerative colitis. Acta Gastroenterol Belg. 2001;64:205-209.
27. Gornet JM, Couve S, Hassani Z, et al. Infliximab for refractory ulcerative colitis or indeterminate colitis: an open-label multicenter study. Aliment Pharmacol Ther. 2003;18:175-181.
28. Gisbert JP, Gomollon F, Mate J, et al. Role of 5-aminosalicylic acid (5-ASA) in treatment of inflammatory bowel disease: as systematic review. Dig Dis Sci. 2002;47:471-488.
29. Su C, Lichtenstein GR. Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurine. Gastroenterol Clin North Am. 2004;33:209-234.
30. Cohen RD, Stein R, Hanauer SB. Intravenous cyclosporin in ulcerative colitis: a five-year experience. Am J Gastroenterol. 1999;94:1587-1592.
31. Becker JM. Surgical therapy for ulcerative colitis and Crohn's disease. Gastroenterol Clin North Am. 1999;28:371-390.
32. Lewis JD, Deren JJ, Lichenstein GR. Cancer risk in patients with inflammatory bowel disease. Gastroenterol Clin North Am. 1999;28:459-477.
33. Gorfine SR, Bauer JJ, Harris MT, et al. Dysplasia complicating chronic ulcerative colitis; is immediate colectomy warranted? Dis Colon Rectum. 2000;43:1575-1581.
34. Parks AG, Nichols RJ. Proctocolectomy without ileostomy for ulcerative colitis. BMJ. 1978;2:85-88.
35. Cima RR, Pemberton JH. Surgical indications and procedures in ulcerative colitis. Curr Treat Options Gastroenterol. 2004;7:181-190.
36. Laureti S, Ugolini F, D'Errico A, et al. Adenocarcinoma below ileoanal anastomosis for ulcerative colitis: report of a case and review of the literature. Dis Colon Rectum. 2002;45:418-421.
37. Rodriguez-Sanjuan JC, Polavieja MG, Naranjo A, et al. Adenocarcinoma in an ileal pouch for ulcerative colitis. Dis Colon Rectum. 1995;38:779-780.
38. Heppell J, Weiland LH, Perrault J, et al. Fate of the rectal mucosa after rectal mucosectomy and ileoanal anastomosis. Dis Colon Rectum. 1983;26:768-771.
39. O'Connell PR, Pemberton JH, Weiland LH, et al. Does rectal mucosa regenerate after ileoanal anastomosis? Dis Colon Rectum. 1987;30:1-5.
40. Reilly WT, Pemberton JH, Wolff BG, et al. Randomized prospective trial comparing ileal pouch-anal anastomosis performed by excising the anal mucosa to ileal pouch-anal anastomosis performed by preserving the anal mucosa. Ann Surg. 1997;225:666-677.
41. Bullard KM, Madoff RD, Gemlo BT. Is ileoanal pouch function stable with time? results of a prospective audit. Dis Colon Rectum. 2002;45:299-304.
42. Farouk R, Pemberton JH, Wolff BG, et al. Functional outcomes after ileal pouchanal anastomosis for chronic ulcerative colitis. Ann Surg. 2000;231:919-926.
43. Fazio VW, Ziv Y, Church JM, et al. Ileal pouch-anal anastomoses complications and function in 1005 patients. Ann Surg. 1995;222:120-127.
44. Sugerman HJ, Sugerman EL, Meador JG, Newsome HH Jr, Kellum JM Jr, De-Maria EJ. Ileal pouch anal anastomosis without ileal diversion Ann Surg. 2000;232:530-541.
45. Heuschen UA, Hinz U, Allemeyer EH, et al. One- or two-stage procedure for restorative proctocolectomy: rationale for a surgical strategy in ulcerative colitis. Ann Surg. 2001;234:788-794.
46. Tjandra JJ, Fazio VW, Milsom JW, et al. Omission of temporary diversion in restorative proctocolectomy: is it safe? Dis Colon Rectum. 1993;36:1007-1014.
47. Grobler SP, Hosie KB, Keighley MRB. Randomized trial of loop ileostomy in restorative proctocolectomy. Br J Surg. 1992;79:903-906.
48. Williamson ME, Lewis WG, Sagar PM, Holdsworth PJ, Johnston D. One-stage restorative proctocolectomy without temporary ileostomy for ulcerative colitis: a note of caution. Dis Colon Rectum. 1997;40:1019-1022.
49. Tan HT, Connolly AB, Morton D, et al. Results of restorative proctocolectomy in the elderly. Int J Colorectal Dis. 1997;12:319-322.
50. Metcalf AM, Dozois RR, Kelly KA. Sexual function after proctocolectomy. Ann Surg. 1986;204:624-627.
51. Bambrick M, Fazio VW, Hull TL, Pucel G. Sexual function following restorative proctocolectomy in women. Dis Colon Rectum. 1996;39:610-614.
52. Olsen KO, Joelsson M, Laurberg S, et al. Fertility after ileal pouch-anal anastomosis in women with ulcerative colitis. Br J Surg. 1999;86:493-495.
53. Olsen KO, Juul S, Bulow S, et al. Female fecundity before and after operation for familial adenomatous polyposis. Br J Surg. 2003;90:227-231.
54. Dunker MS, Bemelman WA, Slors JFM, et al. Functional outcome, quality of life, body image, and cosmesis in patients after laparoscopic-assisted and conventional restorative proctocolectomy: a comparative study. Dis Colon Rectum. 2001;44:1800-1807.
55. Santoro E, Carlini M, Carboni F, Feroce A. Laparoscopic total proctocolectomy with ileal J pouch-anal anastomosis. Hepatogastroenterology. 1999;46:894-899.
56. Young-Fadok TM, Dozois EJ, Sandborn WJ, et al. A case-matched study of laparoscopic proctocolectomy and ileal pouch anal anastomosis (PC-IPAA) versus open PC-IPAA for ulcerative colitis [abstract]. Gastroenterology. 2001;120(suppl 1):A452.
57. Meagher AP, Farouk R, Dozois RR, et al. J ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long-term outcome in 1310 patients. Br J Surg. 1998;85:800-803.
58. Dayton MT, Larsen KP. Outcomes of pouch-related complications after ileal pouchanal anastomosis. Am J Surg. 1997;174:728-732.
59. Romanos J, Samarasekera DN, Stebbing JF, et al. Outcomes of 200 restorative proctocolectomy operations: the John Radcliffe Hospital experience. Br J Surg. 1997;84:814-818.
60. Maclean AR, Cohen Z, MacRae HM, et al. Risk of small bowel obstruction after the ileal pouch-anal anastomosis. Ann Surg. 2002;235:200-206.
61. Galandiuk S, Scott NA, Dozois RR, et al. Ileal pouch-anal anastomosis: reoperation for pouch-related complications. Ann Surg. 1990;212:446-454.
62. Cohen Z, McLeod RS, Stephen W, et al. Continuing evolution of the pelvic pouch procedure. Ann Surg. 1992;216:506-511.
63. Marcello PW, Robert PL, Schoetz DJ Jr, et al. Long-term results of ileoanal pouch procedure. Arch Surg. 1993;128:500-503.
64. Keighley MR, Gobler SP. Fistula complicating restorative proctocolectomy. Br J Surg. 1993;80:1065-1067.
65. Wexner SD, Rothenberger DA, Jensen L, et al. Ileal pouch vaginal fistulas: incidence, etiology, and management. Dis Colon Rectum. 1989;32:460-465.
66. Paye F, Penna C, Chiche L, et al. Pouch-related fistulas following restorative proctocolectomy. Br J Surg. 1996;83:1574-1577.
67. Lohmuller JL, Pemberton JH, Dozois RR, et al. Pouchitis and extraintestinal manifestations of inflammatory bowel disease after ileal pouch-anal anastomosis. Ann Surg. 1990;211:622-629.
68. Korsgen S, Keighley MR. Causes of failure and life expectancy of the ileoanal pouch. Int J Colorectal Dis. 1997;12:4-8.
69. Fonkalsrud EW, Bustorff-Silva J. Reconstruction for chronic dysfunction of ileoanal pouches. Ann Surg. 1999;229:197-204.
70. Fazio VW, Wu JS, Lavery IC. Repeat ileal pouch-anal anastomosis to salvage septic complications of pelvic pouches: clinical outcomes and quality of life assessment. Ann Surg. 1998;228:588-597.
71. Martin A, Dinca M, Leone L, et al. Quality of life after proctocolectomy and ileoanal anastomosis for severe ulcerative colitis. Am J Gastroenterol. 1998;93:166-169.
72. Fazio VW, O'Riordan MG, Lavery IC, et al. Long-term functional outcome and quality of life after stapled restorative proctocolectomy. Ann Surg. 1999;230:575-584.
73. Weinryb RM, Gustavsson JP, Liljeqvist L, et al. A prospective study of the quality of life after pelvic pouch operation. J Am Coll Surg. 1995;180:589-595.
74. Jimmo B, Hyman NH. Is ileal pouch-anal anastomosis really the procedure of choice for patients with ulcerative colitis? Dis Colon Rectum. 1998;41:41-45.
75. O'Bichere A, Wilkinson K, Rumbles S, et al. Functional outcomes after restorative panproctocolectomy for ulcerative colitis decreases an otherwise enhanced quality of life. Br J Surg. 2000;87:802-807.